Home Featured Page 266

Featured

Latest

The Psychedelic News Feed: December 8 – 14, 2025

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy and What Comes Next

The Psychedelic News Feed: December 1 – 7, 2025

The Psychedelic News Feed: November 24 – 30, 2025

PT240 – Ralph Blumenthal – Alien Abductions and The Believer

Tryp Therapeutics Reports on Key Milestones for 2021

Silo Wellness Appoints Phytomedicine Business Leader as Board Member

PharmaTher Announces Submission of IND Application with the FDA for Phase...

The “Equity Elephant”: Why Psychedelic Mutualism and Cooperatives are Crucial for...

Thomas B. Roberts: “Psychedelic Directions, Where Does Your Mind Alight?”

Psychedelic Bulletin: Experts Weigh in on Psilocybin vs. SSRIs; GH Research...

PTSF55 – Creativity, Group Ceremony, and Astral Projection

PharmaTher Provides Update on Psychedelic Product Programs

Silo Wellness Announces Intellectual Property Licensing Agreement of Psilocybin Nasal Spray...

1...265266267...304 Page 266 of 304

The Psychedelic News Feed: December 8 – 14, 2025

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

The Psychedelic News Feed: December 8 – 14, 2025

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy and What Comes Next

The Psychedelic News Feed: December 1 – 7, 2025

The Psychedelic News Feed: November 24 – 30, 2025

PT240 – Ralph Blumenthal – Alien Abductions and The Believer

Tryp Therapeutics Reports on Key Milestones for 2021

Silo Wellness Appoints Phytomedicine Business Leader as Board Member

PharmaTher Announces Submission of IND Application with the FDA for Phase...

The “Equity Elephant”: Why Psychedelic Mutualism and Cooperatives are Crucial for...

Thomas B. Roberts: “Psychedelic Directions, Where Does Your Mind Alight?”

Psychedelic Bulletin: Experts Weigh in on Psilocybin vs. SSRIs; GH Research...

PTSF55 – Creativity, Group Ceremony, and Astral Projection

PharmaTher Provides Update on Psychedelic Product Programs

Silo Wellness Announces Intellectual Property Licensing Agreement of Psilocybin Nasal Spray...

EDITOR PICKS

The Psychedelic News Feed: December 8 – 14, 2025

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY